
NOBEL MEDICAL AS
3086 HOLMESTRAND
Return on Equity
39,45Â %
Current Ratio
4,04
Debt-to-Equity Ratio
−1,32
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | −2 000 | |
Net Income | −101 000 | |
Total Assets | 109Â 000 | |
Total Equity | −256 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | −2 000 | |
Expenditure | 99Â 000 | |
Operating Profit | −101 000 | |
Financial Income | 0 | |
Financial Costs | 0 | |
Financial Balance | 0 | |
Earnings Before Tax | −101 000 | |
Tax | 0 | |
Net Income | −101 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 0 | |
Total Current Assets | 109Â 000 | |
Total Assets | 109Â 000 | |
Total Retained Equity | −286 000 | |
Total Equity | −256 000 | |
Total Long-Term Debt | 338Â 000 | |
Total Current Debt | 27Â 000 | |
Total Equity and Debt | 109Â 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | −2 000 | |
Other Income | 0 | |
Revenue | −2 000 | |
Cost of Goods Sold | 65Â 000 | |
Salary Costs | 0 | |
Depreciation | 0 | |
Impairment | 0 | |
Expenditure | 99Â 000 | |
Operating Profit | −101 000 | |
Financial Income | 0 | |
Financial Costs | 0 | |
Financial Balance | 0 | |
Dividends | 0 | |
Net Income | −101 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 0 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 0 | |
Total Tangible Assets | 0 | |
Total Fiancial Fixed Assets | 0 | |
Total Fixed Assets | 0 | |
Stock | 91Â 000 | |
Total Investments | 0 | |
Cash, Bank | 10Â 000 | |
Total Current Assets | 109Â 000 | |
Total Assets | 109Â 000 | |
Total Equity | −256 000 | |
Short-Term Group Debt | 0 | |
Total Long-Term Debt | 338Â 000 | |
Creditors | 5Â 000 | |
Unpaid Taxes | 0 | |
Dividends | 0 | |
Other Current Debt | 14Â 000 | |
Total Current Debt | 27Â 000 | |
Total Equity and Debt | 109Â 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | 39,45Â % | |
Debt-to-Equity Ratio | −1,32 | |
Operating Profit Margin | 5Â 050Â % | |
Current Ratio | 4,04 | |
Quick Ratio | −1,7 | |
Equity Ratio | −2,35 | |
Gross Profit Margin | 3Â 350Â % |
